Matthew Fogg, MD
Allergy & Immunology · Blue Bell, PANPI 1114920220
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,267 of the $6,942 with a category attached, or 75.9%. 22 manufacturers reported payments, led by Sanofi at 32.5% of the total. Reporting peaked in 2019 at $2,491 and has fallen 76.0% since, to $598 in 2025.
Across 270 payments — averaging $25.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- AstraZeneca$1K
- GSK$1K
- Regeneron Healthcare Solutions, Inc.$957
- Kaleo, Inc.$322
- Amgen$248
- plus $894 from 16 others
What the payments were for
- Consulting fees$1,31619%
- Speaking & faculty fees$3004%
- Food & beverage$5,26776%
- Education$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 27 | $2,253 |
| AstraZeneca | 68 | $1,139 |
| GSK | 70 | $1,129 |
| Regeneron Healthcare Solutions, Inc. | 39 | $957 |
| Kaleo, Inc. | 16 | $322 |
| Amgen(2 entities) | 10 | $248 |
| Genentech USA, Inc. | 7 | $196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $136 |
| Aimmune Therapeutics, Inc. | 4 | $88 |
| Optinose US, Inc. | 4 | $86 |
| CSL Behring | 4 | $85 |
| Covis Pharma GmbH | 4 | $77 |
| Inspire Medical Systems, Inc. | 1 | $50 |
| Blueprint Medicines Corporation | 2 | $50 |
| Exeltis, USA Inc. | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Octapharma USA, Inc. | 1 | $22 |
| Biocryst US Sales Co., LLC | 1 | $17 |
| Alk-abello, Inc | 1 | $13 |
| Merck | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
| Organon | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NO PRODUCT DISCUSSED$1,316
- DUPIXENT$300
How this compares
$6,942 in reported general payments places this provider in the 65th percentile of 175 allergy & immunology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Epinephrine | 17 | $3,443 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 14 | $2,255 |
| Fluticasone Propionate | 44 | $879 |
| Azelastine Hcl | 32 | $802 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $570 |
| Montelukast Sodium | 56 | $439 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Blue Bell
- Robert AnolikBlue Bell$60K
- David KrauseBlue Bell$14K
- Mark PosnerBlue Bell$11K
- Patrick VannelliBlue Bell$7K
- Christine MalloyBlue Bell$7K
- Drew WeissmanPhiladelphia$12.8M
- Eric SchenkelBethlehem$845K
- Sergei BelenkyPittsburgh$775K
- Timothy CraigHershey$564K
- Sandra GawchikUpland$390K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.